Immunopathogenesis of haemorrhagic enteritis virus (HEV) in turkeys

Developmental and Comparative Immunology

Volumn 24, Issue 2-3, 2000, Pages 237-246

  Rautenschlein, Silke ^a   Sharma, Jagdev M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cytokines; HEV; Imidazoquin olinamine; Immunomodulation; Immunosuppression; Model; Pathogenesis; Turkeys

Indexed keywords

INTERFERON; INTERLEUKIN 6; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ANIMAL DISEASE; APOPTOSIS; AVIADENOVIRUS; B LYMPHOCYTE; CORONAVIRUS; CYTOKINE RELEASE; GASTROINTESTINAL HEMORRHAGE; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY; SUDDEN DEATH; T LYMPHOCYTE; TURKEY (BIRD); VETERINARY MEDICINE; VIRUS INHIBITION; VIRUS PATHOGENESIS;

ANIMALIA; AVES; AVIADENOVIRUS; AVIAN ADENOVIRUS; CORONAVIRUS; MELEAGRIS GALLOPAVO;

EID: 0034163282     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(99)00075-0     Document Type: Article

References (73)

1. Pierson W.F., Domermuth C.H. Hemorrhagic enteritis, marble spleen disease, and related infections. Calnek B.W. Diseases of poultry. 10th edn :1997;624-633 Iowa State University Press, Ames, IA.
2. Pomeroy B.S., Fenstermacher R. Hemorrhagic enteritis in turkeys. Poult. Sci. 16:1937;382-387.
3. Larsen C.T., Domermuth C.H., Sponenberg D.P., Gross W.B. Colibacillosis of turkeys exacerbated by hemorrhagic enteritis virus. Laboratory studies. Avian Dis. 29:1985;729-732.
4. Sponenberg D.P., Domermuth C.H., Larsen C.T. Field outbreaks of colibacillosis of turkeys associated with hemorrhagic enteritis virus. Avian Dis. 29:1985;838-842.
5. Newberry L.A., Skeels J.K., Kreider D.L., Beasley J.N., Story J.D., McNew R.W., Berridge B.R. Use of virulent hemorrhagic enteritis virus for induction of colibacillosis in turkeys. Avian Dis. 37:1993;1-5.
6. Saif Y.M. Infectious bursal disease and hemorrhagic enteritis. Poult. Sci. 77:1998;1186-1189.
7. Domermuth C.H., Gross W.B. Hemorrhagic enteritis and related infections. Calnek G.W., Barnes H.J., Beard C.W., Reid W.M., Yoder H.W. Jr. Diseases of poultry. 9th edn. 1991;567-572 Iowa University Press, Ames, IA.
8. Suresh M., Sharma J.M. Pathogenesis of type II avian adenovirus infection in turkeys: in vivo immune cell tropism and tissue distribution of the virus. J. Virol. 70:1996;30-36.
9. Fasina S.O., Fabricant J. Immunofluorescence studies on the early pathogenesis of hemorrhagic enteritis virus infection in turkeys and chickens. Avian Dis. 26:1982;158-163.
10. Fujiwara H., Tanaami S., Yamaguchi M., Yoshino T. Histopathology of hemorrhagic enteritis in turkeys. Natl. Inst. Anim. Health Q. (Tokyo). 15:1975;68-75.
11. Suresh M., Sharma J.M. Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis. Vet. Immunol. Immunopathol. 45:1995;139-150.
12. Rautenschlein S. Immunomodulatory effects of cytokines in turkeys and the role of cytokines on the pathogenesis of infectious diseases. Ph.D. dissertation. University of Minnesota, St. Paul, MN, 1998.
13. Saunders G.K., Pierson F.W., van den Hurk J.V. Haemorrhagic enteritis virus infection in turkeys: a comparison of virulent and avirulent virus infection, and a proposed pathogenesis. Avian Pathol. 22:1993;47-58.
14. Rautenschlein S., Suresh M., Neumann U., Sharma J.M. Comparative pathogenesis of haemorrhagic enteritis virus (HEV) infection in turkeys and chickens. J. Comp. Pathol. 119:1998;251-261.
15. Hussain I., Choi C.U., Rings B.S., Shaw D.P., Nagaraja K.V. Pathogenesis of hemorrhagic enteritis virus infection in turkeys. J. Vet. Med. 40:1993;715-726.
16. Rautenschlein S., Neumann U. Aspects of immunopathogenesis of hemorrhagic enteritis virus infection in turkeys. Keystone Symposia on molecular and cellular biology. J. Cell. Biochem. 19A:1995;263. Suppl.
17. Opengart K.N., Eyre P., Domermuth C.H. Increased numbers of duodenal mast cells in turkeys incubated with hemorrhagic enteritis virus. Am. J. Vet. Res. 53:1992;814-819.
18. Ossa J.E., Alexander J., Schurig G.G. Role of splenectomy in prevention of hemorrhagic enteritis and death from hemorrhagic enteritis virus in turkeys. Avian Dis. 25:1983;1106-1111.
19. Van den Hurk J.V. Characterization of the structural proteins of hemorrhagic enteritis virus. Arch. Virol. 126:1992;195-213.
20. Ladish S., Lovejoy F.H., Hierholzer J.C., Oxman M.N., Strieder D., Vawter G.F., Finer N., Moore M. Extrapulmonary manifestation of adenovirus toxin. J. Pediat. 95:1979;348-355.
21. Rautenschlein S. Ontogenetische Studie zur Empfaenglichkeit von Pute und Huhn fuer das Virus der Haemorrhagischen Enteritis (HEV). Hannover, Tieraerztliche Hochschule, Dissertation, 1994.
22. Nazerian K., Fadly A.M. Propagation of virulent and avirulent turkey hemorrhagic enteritis virus in cell culture. Avian Dis. 26:1982;816-827.
23. Fadly A.M., Nazerian K. Evidence for bursal involvement in the pathogenesis of hemorrhagic enteritis of turkeys. Avian Dis. 26:1982;525-533.
24. Gross W.B., Domermuth C.H. Spleen lesions of hemorrhagic enteritis in turkeys. Avian Dis. 20:1976;455-466.
25. Schmid I., Uittenbogaart C.H., Giorgi J. Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry. Cytometry. 15:1994;12-20.
26. Nagaraja K.V., Emery D.A., Patel B.S., Pomeroy B.S., Newman J.A. In vitro evaluation of B-lymphocyte function in turkeys infected with hemorrhagic enteritis virus. Am. J. Vet. Res. 43:1982;502-504.
27. Nagaraja K.V., Patel B.L., Emery D.A., Pomeroy B.A., Newman J.A. In vitro depression of the mitogenic response of lymphocytes from turkeys infected with hemorrhagic enteritis virus. Am. J. Vet. Res. 43:1982;134-136.
28. Nagaraja K.V., Kang S.Y., Newman J.A. Immunosuppressive effects of virulent strain of hemorrhagic enteritis virus in turkeys against Newcastle disease. Poult. Sci. 64:1985;588-590.
29. Razin E., Ihle J.N., Seldin D., Mencia-Huerta J.M., Katz H.R., LeBlanc P.A., Hein A., Caulfied J.P., Austen K.F., Stevens R.L. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J. Immunol. 132:1984;1479-1486.
30. Rautenschlein S, Sharma JM. Response of turkeys to simultaneous vaccination with hemorrhagic enteritis and Newcastle disease viruses. Avian Dis 1999;43:286-92.
31. Pertile T.L., Sharma J.M., Walser M.M. Reovirus infection in chickens primes splenic adherent macrophages to produce nitric oxide in response to T cell-produced factors. Cell. Immunol. 164:1995;207-216.
32. Reiss C.S., Komatsu T. Does nitric oxide play a critical role in viral infections? J. Virol. 72:1998;4547-4551.
33. Ginsberg H.S., Moldawer L.L., Sehgal P.B., Redington M., Kilian P.L., Chanock R.M., Prince G.A. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci., U.S.A. 88:1991;1651-1655.
34. Mistchenko A.S., Diez R.A., Mariani A.L., Robaldo J., Maffey A.F., Bayley-Bustamante G., Grinstein S. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J. Pediat. 124:1994;714-725.
35. Tracey K.J., Beutler B., Lowry S.F., Merryweather J., Wolpe S., Milsark I.W., Hariri R.J., Fahey III T.J., Zentella A., Albert J.D., Shires G.T., Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
36. Tracey K.J., Lowry S.F., Fahey III T.J., Albert J.D., Fong Y., Hesse D., Beutler K.R., Manogue K.R., Calvano S., Wei H., Cerami A., Shires G.T. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 1649:1987;415-422.
37. Sampaio E.P., Sarno E.N., Galilly R., Cohn Z.A., Kaplan G. Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J. Exp. Med. 173:1991;699-703.
38. Darji A., Beschin A., Sileghem M., Heremans H., Brys L., De Baetselier P. In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect. Immun. 64:1996;1937-1943.
39. Nokta M.A., Hassan M.I., Loesch K., Pollard R.B. Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes. J. Clin. Invest. 97:1996;2635-2641.
40. Haq A.U. The effect of interferon gamma and alpha on Con-A stimulated T-cell proliferation: role of monocytes. Am. J. Med. Sci. 292:(6):1986;350-355.
41. Krenger W., Falzarano G., Delmonte J. Jr., Snyder K.M., Byon J.C., Ferrara J.L. Interferon gamma suppresses T-cell proliferation to mitogen via the NO pathway during experimental acute graft-versus-host disease. Blood. 88:1996;1113-1121.
42. Krishnaswamy G., Smith J.K., Srikanth S., Chi D.S., Kalbfleisch J.H., Huang S.K. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J. Interferon Cytokine Res. 16:1996;819-827.
43. Domermuth C.H., Gross W.B., Douglass C.S., DuBose R.T., Harris J.R., Davis R.B. Vaccination for hemorrhagic enteritis of turkeys. Avian Dis. 21:1977;557-565.
44. Neumann U., Sander I., Behr H-P., Baron G., Rautenschlein S. Clinical, postmortem and immunological observations following application of a live vaccine against turkey hemorrhagic enteritis (HE). Proceedings of the International Symposium on Adenovirus and Reovirus Infections in Poultry, Rauischholzhausen, Germany, June 24th-27th :1996;61-74.
45. Sharma J.M. Response of specific-pathogen-free turkeys to vaccines derived from marble spleen disease virus and hemorrhagic enteritis. Avian Dis. 38:1994;523-530.
46. Pierson F.W., Larsen C.T., Domermuth C.H. The production of colibacillosis in turkeys following sequential exposure to Newcastle disease virus or Bordetella avium, avirulent hemorrhagic enteritis virus, and Escherichia coli. Avian Dis. 40:1996;837-840.
47. Cardona C.J., Reed W. Construction and in vitro analysis of a recombinant fowlpox virus expressing the native hexon of hemorrhagic enteritis virus. AVMA, July 19th-24th, Reno, Nevada, USA :1997.
48. Cardona C.J., Reed W.M. Protection against challenge with virulent hemorrhagic enteritis virus (HEV) by a recombinant fowlpox virus expressing the hexon of HEV. AVMA, July 25th-29th, Baltimore, MD, USA :1997.
49. Van den Hurk J.V., van Drunen Little-van den Hurk S. Protection of turkeys against haemorrhagic enteritis virus by monoclonal antibodies and hexon immunization. Vaccine. 11:1993;329-335.
50. Bernstein D.I., Miller R.L., Harrison C.J. Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea pigs when begun after lesion development. Antiviral Res. 20:1993;45-55.
51. Bernstein D.I., Harrison C.J. Effects of the immunomodulating agent R-837 on acute and latent herpes simplex virus type 2 infections. Antimicrob. Agents Chemother. 33:1989;1511-1515.
52. Bernstein D.I., Miller R.L., Harrison C.J. Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea pigs when begun after lesion development. Antiviral Res. 20:1993;45-55.
53. Chen M., Griffith B.P., Lucia H.L., Hiung G.D. Efficacy of S-26308 against guinea pig cytomegalo virus. Antimicrob. Agents Chemotherapy. 32:1988;678-683.
54. Harrison C.J., Stanberry L.R., Bernstein D.I. Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs. Antiviral Res. 15:1991;315-322.
55. Kende M.J., Lupton H.W., Canonico P.G. Treatment of viral infections with immunomodulators. Adv. Biosci. 68:1988;51-63.
56. Miller R.L., Imbertson L.M., Reiter M.J., Schwartzmiller D.H., Pecore S.E., Gerster J.F. Inhibition of herpes simplex virus infection in a guinea pig model by S-26308 (abstract). ASM, 26th Interscience Conference on Antimicrobial Agents and Chemotherapy :1985;235.
57. Miller R.L., Birmchu W., Gerster J., Gibson S., Imbertson L., Reiter M., Scribner L., Wagner T., Weeks C., Tomai M. Imiquimod: cytokine induction and antiviral activity. Int. Antiviral News. 3:1995;111-113.
58. Beutner K.R., Tyring S.K., Trofatter K.F. Jr., Douglas J.M. Jr., Spruance S., Owens M.L., Fox T.L., Hougham A.J., Schmitt K.A. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob. Agents Chemother. 42:1998;789-794.
59. Edwards L., Ferenczy A., Eron L., Baker D., Owens M.L., Fox T.L., Hougham A.J., Schmitt K.A. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human papilloma virus. Arch. Dermatol. 134:1998;25-30.
60. Syed T.A., Goswami J., Ahmadpour O.A., Ahmad S.A. Treatment of moluscum contagiosum in males with an analogue of imiquimod 1% in cream. A placebocontrolled, double-blind study. J. Dermatol. 25:1998;309-313.
61. Sen G.C., Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267:(8):1992;5017-5020.
62. Schijns V.E., Claassen I.J., Vermeulen A.A., Horzinek M.C., Osterhaus A.D.M.E. Modulation of antiviral immune responses by exogenous cytokines: effects of tumor necrosis factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 75:1994;55-63.
63. Rautenschlein S., Miller R.L., Sharma J.M. Interferon induction in turkeys by oral administration of the imidazoquinolinamine S-28828 and modulation of the pathogenesis of Escherichia coli. Vet. Immunol. Immunopathol. 66:1998;127-141.
64. Deguchi M., Inaba K., Muramatsu S. Counteracting effect of interferon-alpha and -beta and interferon-gamma-induced production of nitric oxide which is suppressive for antibody response. Immunol. Lett. 45:(3):1995;157-162.
65. Martin C., Biosson C., Haccoun M., Thomachot L., Mege J.L. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit. Care Med. 25:1997;1813-1819.
66. Aikawa N., Fujishima S., Shinozawa Y., Hori S. Cytokine-mediated biological response to severe infections in surgical patients. Nippon Geka Gakkai Zasshi. J. Japan Surg. Soc. 97:1996;1054-1059.
67. Rautenschlein S., Sharma J.M., Cytokines. Pastoret P-P., Griebel P., Bazin H., Govaerts A. Handbook of vertebrate immunology. 1998;95-98 Academic Press, London.
68. Karaca K., Sharma J.M., Tomai M.A., Miller R.L. In vivo and in vitro interferon induction in chickens by S-28828, an imidazoquinolinamine immunoenhancer. J. Interferon Cytokine Res. 16:1996;327-332.
69. Sekellick M.J., Ferrandino A.F., Hopkins D.A., Marcus P.I. Chicken interferon gene: cloning, expression, and analysis. J. Interferon Res. 14:1994;71-79.
70. Helle M., Boeije L., Aarden L.A. Functional discrimination between interleukin 6 and interleukin 1. Eur. J. Immunol. 18:1988;1535-1540.
71. Rath N.C., Huff W.E., Bayyari G.R., Balog J.M. Identification of transforming growth factor-β and interleukin-6 in chicken ascites fluid. Avian Dis. 39:1995;382-389.
72. Zhang S., Lillehoj H.S., Ruff M.D. Chicken tumor necrosis-like factor. I. In vitro production by macrophages stimulated with Eimeria tenella or bacterial lipopolysaccharide. Poult. Sci. 74:1995;1304-1310.
73. Aggarwal B.B., Kohr W.J., Hass P.E., Moffat B., Spencer S.A., Henzel W.J., Bringman S., Nedwin G.E., Goeddel D.V., Harkins R.N. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem. 260:1985;2345-2354.